Net Cash Provided by (Used in) Financing Activities in USD of NOVAVAX INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NOVAVAX INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • NOVAVAX INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was -$7.06M, a 220% decline year-over-year.
  • NOVAVAX INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $261M, a 5735% increase from 2023.
  • NOVAVAX INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.47M, a 98.6% decline from 2022.
  • NOVAVAX INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $325M, a 29.6% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NOVAVAX INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$7.06M -$12.9M -220% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q1 2024 $5.89M +$360M 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q1 2023 -$354M -$514M -322% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q1 2022 $160M -$417M -72.3% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q1 2021 $577M +$391M +210% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q1 2020 $186M +$130M +231% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q1 2019 $56.2M +$12.3M +27.9% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 $43.9M +$28.6M +186% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q1 2017 $15.4M 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q1 2014 $1.17M -$6.01M -83.7% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2014
Q1 2013 $7.18M -$78K -1.08% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q1 2012 $7.26M +$5.91M +437% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013
Q1 2011 $1.35M 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012

NOVAVAX INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $261M +$256M +5735% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 $4.47M -$321M -98.6% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $325M -$137M -29.6% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 $462M -$523M -53.1% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $985M +$886M +901% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $98.4M -$4.42M -4.3% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 $103M +$38.3M +59.3% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 $64.5M -$215M -76.9% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020
2016 $280M +$71.6M +34.4% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019
2015 $208M 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018
2012 $53.8M +$42.7M +383% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2013
2011 $11.1M -$12.3M -52.5% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2013
2010 $23.4M 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.